Cargando…
Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567096/ https://www.ncbi.nlm.nih.gov/pubmed/26509180 http://dx.doi.org/10.1093/ofid/ofv057 |
_version_ | 1782389775248916480 |
---|---|
author | O’Brien, Thomas R. Pfeiffer, Ruth M. |
author_facet | O’Brien, Thomas R. Pfeiffer, Ruth M. |
author_sort | O’Brien, Thomas R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4567096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45670962015-10-27 Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C O’Brien, Thomas R. Pfeiffer, Ruth M. Open Forum Infect Dis Correspondence Oxford University Press 2015-04-20 /pmc/articles/PMC4567096/ /pubmed/26509180 http://dx.doi.org/10.1093/ofid/ofv057 Text en Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
spellingShingle | Correspondence O’Brien, Thomas R. Pfeiffer, Ruth M. Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title | Reply: Subgroup Differences in Response to 8 Weeks of
Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title_full | Reply: Subgroup Differences in Response to 8 Weeks of
Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title_fullStr | Reply: Subgroup Differences in Response to 8 Weeks of
Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title_full_unstemmed | Reply: Subgroup Differences in Response to 8 Weeks of
Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title_short | Reply: Subgroup Differences in Response to 8 Weeks of
Ledipasvir/Sofosbuvir for Chronic Hepatitis C |
title_sort | reply: subgroup differences in response to 8 weeks of
ledipasvir/sofosbuvir for chronic hepatitis c |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567096/ https://www.ncbi.nlm.nih.gov/pubmed/26509180 http://dx.doi.org/10.1093/ofid/ofv057 |
work_keys_str_mv | AT obrienthomasr replysubgroupdifferencesinresponseto8weeksofledipasvirsofosbuvirforchronichepatitisc AT pfeifferruthm replysubgroupdifferencesinresponseto8weeksofledipasvirsofosbuvirforchronichepatitisc |